BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lembo A, Kelley JM, Nee J, Ballou S, Iturrino J, Cheng V, Rangan V, Katon J, Hirsch W, Kirsch I, Hall K, Davis RB, Kaptchuk TJ. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain 2021. [PMID: 33605656 DOI: 10.1097/j.pain.0000000000002234] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 de Bruijn CMA, Benninga MA, Vlieger AM. Teenagers' and parental attitudes towards the use of placebo pills. Eur J Pediatr 2023;182:1425-8. [PMID: 36607409 DOI: 10.1007/s00431-022-04801-4] [Reference Citation Analysis]
2 Jan Pawlik R, Aulenkamp J, Elsenbruch S. Wenn aus einem Bauchgefühl viszerale Schmerzen werden: Placebo- und Nocebo-Mechanismen entlang der Darm-Hirn-Achse. Aktuelle Ernährungsmedizin 2023;48:37-45. [DOI: 10.1055/a-1976-9382] [Reference Citation Analysis]
3 Schaefer M, Kühnel A, Schweitzer F, Enge S, Gärtner M. Neural underpinnings of open-label placebo effects in emotional distress. Neuropsychopharmacology 2023;48:560-6. [PMID: 36456814 DOI: 10.1038/s41386-022-01501-3] [Reference Citation Analysis]
4 Blease C, Colagiuri B, Locher C. Replication crisis and placebo studies: rebooting the bioethical debate. J Med Ethics 2023:jme-2022-108672. [PMID: 36609361 DOI: 10.1136/jme-2022-108672] [Reference Citation Analysis]
5 Locher C, Koechlin H. Do expectations influence pain? Recognizing Irving Kirsch's contribution to our understanding of pain. Am J Clin Hypn 2023;65:211-22. [PMID: 36219555 DOI: 10.1080/00029157.2022.2121677] [Reference Citation Analysis]
6 Vázquez-Frias R, Consuelo-Sánchez A, Acosta-Rodríguez-Bueno CP, Blanco-Montero A, Robles DC, Cohen V, Márquez D, Perez M 3rd. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Paediatr Drugs 2023;25:115-26. [PMID: 36380186 DOI: 10.1007/s40272-022-00536-9] [Reference Citation Analysis]
7 Sezer D, Locher C, Gaab J. Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects. Sci Rep 2022;12:21219. [PMID: 36481801 DOI: 10.1038/s41598-022-25446-1] [Reference Citation Analysis]
8 Sharma T, Ma C, Sedano R, Hanzel J, McDonald C, Hogan M, Kochhar GS, Narula N, Peyrin-Biroulet L, Danese S, MacDonald JK, Jairath V. Placebo response rates in randomized controlled trials for perianal Crohn's disease: A systematic review and meta-analysis. J Crohns Colitis 2022:jjac160. [PMID: 36271904 DOI: 10.1093/ecco-jcc/jjac160] [Reference Citation Analysis]
9 Kube T, Kirsch I, Glombiewski JA, Herzog P. Can placebos reduce intrusive memories? Behav Res Ther 2022;158:104197. [PMID: 36122440 DOI: 10.1016/j.brat.2022.104197] [Reference Citation Analysis]
10 Tsai I, Hsu C, Chang C, Tseng P, Chang K. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Pharmacol 2022;13:883251. [DOI: 10.3389/fphar.2022.883251] [Reference Citation Analysis]
11 Hruschak V, Flowers KM, Patton M, Merchantz V, Schwartz E, Edwards R, Kaptchuk T, Kang J, Dossett M, Schreiber K. Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery. Int J Behav Med 2022. [PMID: 35915346 DOI: 10.1007/s12529-022-10114-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Almradi A, Sedano R, Hogan M, Zou GY, MacDonald JK, Parker CE, Hanzel J, Crowley E, Singh S, D'Haens G, Sandborn WJ, Feagan BG, Ma C, Jairath V. Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials. J Crohns Colitis 2022;16:717-36. [PMID: 34758084 DOI: 10.1093/ecco-jcc/jjab194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Meijer S, van Middendorp H, Peerdeman KJ, Evers AWM. Counterconditioning as Treatment to Reduce Nocebo Effects in Persistent Physical Symptoms: Treatment Protocol and Study Design. Front Psychol 2022;13:806409. [DOI: 10.3389/fpsyg.2022.806409] [Reference Citation Analysis]
14 Nurko S, Saps M, Kossowsky J, Zion SR, Di Lorenzo C, Vaz K, Hawthorne K, Wu R, Ciciora S, Rosen JM, Kaptchuk TJ, Kelley JM. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial. JAMA Pediatr 2022;176:349-56. [PMID: 35099543 DOI: 10.1001/jamapediatrics.2021.5750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Friehs T, Rief W, Glombiewski JA, Haas J, Kube T. Deceptive and non-deceptive placebos to reduce sadness: A five-armed experimental study. Journal of Affective Disorders Reports 2022. [DOI: 10.1016/j.jadr.2022.100349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Seetharaman J, Poddar U, Yachha SK, Srivastava A, Sen Sarma M. Efficacy of amitriptyline in pediatric functional abdominal pain disorders: A randomized placebo-controlled trial. J Gastroenterol Hepatol 2022;37:685-91. [PMID: 34935191 DOI: 10.1111/jgh.15765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang R, Lembo AJ, Kaptchuk TJ, Cheng V, Nee J, Iturrino J, Rao M, Loscalzo J, Silvester JA, Hall KT. Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome. Front Pain Res 2022;2:775386. [DOI: 10.3389/fpain.2021.775386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ashar YK, Gordon A, Schubiner H, Uipi C, Knight K, Anderson Z, Carlisle J, Polisky L, Geuter S, Flood TF, Kragel PA, Dimidjian S, Lumley MA, Wager TD. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry 2022;79:13-23. [PMID: 34586357 DOI: 10.1001/jamapsychiatry.2021.2669] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
19 Vollert J, Wang R, Regis S, Yetman H, Lembo AJ, Kaptchuk TJ, Cheng V, Nee J, Iturrino J, Loscalzo J, Hall KT, Silvester JA. Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome. Front Psychiatry 2022;13:842030. [PMID: 35401282 DOI: 10.3389/fpsyt.2022.842030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rosenkjær S, Lunde SJ, Kirsch I, Vase L. Expectations: How and when do they contribute to placebo analgesia? Front Psychiatry 2022;13:817179. [PMID: 36147975 DOI: 10.3389/fpsyt.2022.817179] [Reference Citation Analysis]
21 Benson S, Theysohn N, Kleine-Borgmann J, Rebernik L, Icenhour A, Elsenbruch S. Positive Treatment Expectations Shape Perceived Medication Efficacy in a Translational Placebo Paradigm for the Gut-Brain Axis. Front Psychiatry 2022;13:824468. [PMID: 35401247 DOI: 10.3389/fpsyt.2022.824468] [Reference Citation Analysis]
22 Rexwinkel R, Vlieger AM, Saps M, Tabbers MM, Benninga MA. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. Eur J Pediatr 2022;181:2603-17. [PMID: 35460383 DOI: 10.1007/s00431-022-04459-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Aulenkamp J, Steinmüller K, Icenhour A, Elsenbruch S. [From gut feeling to visceral pain : Effects of negative expectations in the context of the gut-brain axis]. Schmerz 2021. [PMID: 34940915 DOI: 10.1007/s00482-021-00614-w] [Reference Citation Analysis]
24 Sezer D, de Leeuw M, Netzer C, Dieterle M, Meyer A, Buergler S, Locher C, Ruppen W, Gaab J, Schneider T. Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial. Front Med (Lausanne) 2021;8:687398. [PMID: 34805194 DOI: 10.3389/fmed.2021.687398] [Reference Citation Analysis]
25 Nee J, Ballou S, Kelley JM, Kaptchuk TJ, Hirsch W, Katon J, Cheng V, Rangan V, Lembo A, Iturrino J. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Am J Gastroenterol 2021;116:2279-85. [PMID: 34319275 DOI: 10.14309/ajg.0000000000001395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
26 Locher C, Buergler S, Frey Nascimento A, Kost L, Blease C, Gaab J. Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial. BMJ Open 2021;11:e053346. [PMID: 34408060 DOI: 10.1136/bmjopen-2021-053346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Friesen C, Colombo JM, Deacy A, Schurman JV. An Update on the Assessment and Management of Pediatric Abdominal Pain. Pediatric Health Med Ther 2021;12:373-93. [PMID: 34393542 DOI: 10.2147/PHMT.S287719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Bliamptis J, Barnhill A. Physician perspectives on placebo ethics. J Med Ethics 2021:medethics-2021-107446. [PMID: 34257086 DOI: 10.1136/medethics-2021-107446] [Reference Citation Analysis]
29 Liu T. Placebo Effects: A New Theory. Clinical Psychological Science 2022;10:27-40. [DOI: 10.1177/21677026211009799] [Reference Citation Analysis]